137 related articles for article (PubMed ID: 9284733)
1. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
[TBL] [Abstract][Full Text] [Related]
2. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
[TBL] [Abstract][Full Text] [Related]
3. Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
Mauras N; Horber FF; Haymond MW
J Clin Endocrinol Metab; 1992 Nov; 75(5):1192-7. PubMed ID: 1430078
[TBL] [Abstract][Full Text] [Related]
4. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin.
Bermann M; Jaffe CA; Tsai W; DeMott-Friberg R; Barkan AL
J Clin Invest; 1994 Jul; 94(1):138-45. PubMed ID: 7913710
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
8. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
Mauras N
J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
[TBL] [Abstract][Full Text] [Related]
9. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
Rosenthal SM; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
[TBL] [Abstract][Full Text] [Related]
10. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
Clemmons DR; Smith-Banks A; Underwood LE
J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
Mauras N; Beaufrere B
J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.
Corpas E; Harman SM; Piñeyro MA; Roberson R; Blackman MR
J Clin Endocrinol Metab; 1992 Aug; 75(2):530-5. PubMed ID: 1379256
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.
Boulware SD; Tamborlane WV; Rennert NJ; Gesundheit N; Sherwin RS
J Clin Invest; 1994 Mar; 93(3):1131-9. PubMed ID: 8132753
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults.
Young SC; Underwood LE; Celniker A; Clemmons DR
J Clin Endocrinol Metab; 1992 Aug; 75(2):603-8. PubMed ID: 1379258
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
[TBL] [Abstract][Full Text] [Related]
18. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.
Turkalj I; Keller U; Ninnis R; Vosmeer S; Stauffacher W
J Clin Endocrinol Metab; 1992 Nov; 75(5):1186-91. PubMed ID: 1430077
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between insulin-like growth factors-I and -II in central regulation of pulsatile growth hormone secretion.
Harel Z; Tannenbaum GS
Endocrinology; 1992 Aug; 131(2):758-64. PubMed ID: 1639021
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone treatment in man induces changes in 24-hour growth hormone (GH) secretion profile without altering total GH released.
Pralong FP; Miell JP; Corder R; Gaillard RC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1191-6. PubMed ID: 1955500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
